CAS: 404951-53-7 - 3-[4-[N-(2-Hydroxyethyl)-N-[2-(1H-indol-3-yl)ethyl]aminomethyl]phenyl]-2(E)-propenohydroxamic acid
Formula:C22H25N3O3
InChI:InChI=1S/C22H25N3O3/c26-14-13-25(12-11-19-15-23-21-4-2-1-3-20(19)21)16-18-7-5-17(6-8-18)9-10-22(27)24-28/h1-10,15,23,26,28H,11-14,16H2,(H,24,27)/b10-9+
InChI key:InChIKey=BWDQBBCUWLSASG-MDZDMXLPSA-N
SMILES:O=C(C=CC1=CC=C(C=C1)CN(CCO)CCC2=CNC=3C=CC=CC32)NO
- Synonyms:
- (2E)-N-Hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide
- (2E)-N-hydroxy-3-[4-({(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino}methyl)phenyl]prop-2-enamide
- 2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)-
- Dacinostat
- Laq-824
- Nvp-Laq-824
2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)-
CAS:404951-53-7
Formula:
C22H25N3O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
379.4522
Ref: IN-DA00BXVU
5mg | 199.00 € | ||
10mg | 237.00 € | ||
50mg | To inquire | ||
100mg | To inquire | ||
200mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Dacinostat
CAS:404951-53-7
LAQ824 (Dacinostat (NVP-LAQ824)) is a novel HDAC inhibitor with IC50 of 32 nM and is …
Formula:
C22H25N3O3
Purity:
95.28% - 95.28%
Color and Shape:
Solid
Molecular weight:
379.45
Ref: TM-T2454
1mg | 49.00 € | ||
2mg | 67.00 € | ||
5mg | 108.00 € | ||
10mg | 177.00 € | ||
25mg | 315.00 € | ||
50mg | 477.00 € | ||
100mg | 690.00 € | ||
500mg | 1,420.00 € | ||
1mL*10mM (DMSO) | 110.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Dacinostat
Controlled ProductCAS:404951-53-7
Formula:
C22H25N3O3
Color and Shape:
Neat
Molecular weight:
379.452
Ref: TR-D101580
250mg | 3,575.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
Dacinostat
CAS:404951-53-7
Inhibitor of histone deacetylases HDAC1 and HDAC2
Formula:
C22H25N3O3
Purity:
Min. 95%
Molecular weight:
379.45 g/mol
Ref: 3D-FD43358
10mg | To inquire | ||
50mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025